Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Total Current Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Total Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Current Liabilities ₹1,608 Cr₹1,565 Cr₹1,398 Cr₹729 Cr₹582 Cr

What is the latest Total Current Liabilities ratio of GLAND PHARMA ?

The latest Total Current Liabilities ratio of GLAND PHARMA is ₹1,608 Cr based on Mar2026 Consolidated results.
Year Total Current Liabilities
Mar2026₹1,608 Cr
Mar2025₹1,565 Cr
Mar2024₹1,398 Cr
Mar2023₹729 Cr
Mar2022₹582 Cr

How is Total Current Liabilities of GLAND PHARMA Trending?

Years Total Current Liabilities % Change
Mar2026 ₹1,608 Cr
2.78
Mar2025 ₹1,565 Cr
11.91
Mar2024 ₹1,398 Cr
91.78
Mar2023 ₹729 Cr
25.28
Mar2022 ₹582 Cr -

Compare Total Current Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,004.1 Cr 1.2% -0.2% 22.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

1.2%

-0.2%

22.6%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses